Prasugrel as a potential cancer promoter: review of the unpublished data.
Floyd
James S
JS
Cardiovascular Health Research Unit, Department of Medicine, University of Washington, 1730 Minor Ave, Ste 1360, Box 358085, Seattle, WA 98101, USA. jfloyd@u.washington.edu
Serebruany
Victor L
VL
D054058:Acute Coronary Syndrome / Q000188:drug therapy; D006801:Humans; D015994:Incidence; D009369:Neoplasms / Q000139:chemically induced* / Q000453:epidemiology; D010506:Periodicals as Topic; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D000068799:Prasugrel Hydrochloride; D058919:Purinergic P2 Receptor Antagonists; D012307:Risk Factors; D013876:Thiophenes / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology
D010879:Piperazines; D058919:Purinergic P2 Receptor Antagonists; D013876:Thiophenes; D000068799:Prasugrel Hydrochloride